| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Sachetta Eric serves as a Director at SRTS. Across recent SEC filings that breaks down to 9 buys and 0 sells. Those positions are worth an estimated $1.0M at current prices.
Historically, Sachetta Eric's trades have earned a below-average insider score of 37/100 across 3 rated trades. On a 3-month view, 33.3% of the rated trades came out ahead, averaging -4.2% over three months.
The biggest single holding is SRTS (~$1.0M) as Director. Net of sales, the recent Form 4 record there shows accumulation of 143,538 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | SRTS Sensus Healthcare, Inc. | Director | Buy | 64,841 | $3.48 | $225,616.22 | +13.0% | - | - | |
| Aug 24, 2026 | SRTS Sensus Healthcare, Inc. | Director | Buy | 34,697 | $3.25 | $112,904.04 | +19.9% | - | - | |
| Aug 21, 2026 | SRTS Sensus Healthcare, Inc. | Director | Buy | 31,000 | $3.16 | $97,850.00 | +10.0% | - | - | |
| May 12, 2026 | SRTS Sensus Healthcare, Inc. | Director | Buy | 1,500 | $3.34 | $5,002.50 | +1.1% | - | - | |
| Feb 24, 2026 | SRTS Sensus Healthcare, Inc. | Director | Buy | 2,000 | $3.81 | $7,620.00 | +1.4% | -16.7% | - | |
| Nov 21, 2025 | SRTS Sensus Healthcare, Inc. | Director | Buy | 7,000 | $3.93 | $27,510.00 | +5.3% | -2.7% | - | |
| Nov 13, 2025 | SRTS Sensus Healthcare, Inc. | Director | Buy | 2,500 | $4.50 | $11,250.00 | +1.9% | +6.7% | - |